Package 68001-130-00
Brand: amlodipine besylate and benazepril hydrochloride
Generic: amlodipine besylate and benazepril hydrochloridePackage Facts
Identity
Package NDC
68001-130-00
Digits Only
6800113000
Product NDC
68001-130
Description
100 CAPSULE in 1 BOTTLE (68001-130-00)
Marketing
Marketing Status
Brand
amlodipine besylate and benazepril hydrochloride
Generic
amlodipine besylate and benazepril hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "facbe2e1-8ede-d7e4-e053-6394a90ae44f", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898346", "898350", "898353", "898356", "898359"], "spl_set_id": ["df8e23c8-6c8f-4293-8a37-5ad3d48dba94"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68001-130-00)", "package_ndc": "68001-130-00", "marketing_start_date": "20150716"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "68001-130_facbe2e1-8ede-d7e4-e053-6394a90ae44f", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "68001-130", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20150716", "listing_expiration_date": "20261231"}